Qube Research & Technologies (QRT)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$76.4K Sell
500
-1,700
-77% -$261K ﹤0.01% 3111
2025
Q4
$303K Sell
2,200
-800
-27% -$105K ﹤0.01% 2947
2025
Q3
$385K Sell
3,000
-700
-19% -$85.4K ﹤0.01% 2779
2025
Q2
$448K Buy
3,700
+900
+32% +$101K ﹤0.01% 2721
2025
Q1
$312K Buy
2,800
+1,800
+180% +$192K ﹤0.01% 2720
2024
Q4
$97.3K Buy
1,000
+800
+400% +$85.3K ﹤0.01% 2998
2024
Q3
$23K Buy
+200
New +$22.7K ﹤0.01% 2961

Other funds holding NVS

Qube Research & Technologies (QRT)'s NVS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Novartis (NVS) stake by 46% in Q1 2026, buying an estimated $8.36M and bringing the position to 173,137 shares worth $26.4M. The position accounts for 0.03% of the portfolio, ranked #720.

Qube Research & Technologies (QRT) first reported a position in NVS in Q4 2019 and has held it in 21 quarters since. The position peaked at $70.6M in Q1 2024. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Qube Research & Technologies (QRT) held 173,137 shares of Novartis worth $26.4M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 54,510 Novartis shares in Q1 2026, an estimated $8.36M.
  • Novartis made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #720 holding.
  • Qube Research & Technologies (QRT) first reported a position in Novartis in Q4 2019 and has held it in 21 quarters since.
  • Qube Research & Technologies (QRT)'s Novartis position peaked at $70.6M in Q1 2024.
  • 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.